Hypergendered Logic Source
Hypergendered Logic — Page 289
top. Every elevator has two different controls. Hormone amount controls how soon the elevator makes its next move. Receptor sensitivity controls how many floors it jumps when it moves. Turning one control does not automatically turn the other. A doctor therefore needs to know both "how often will movement happen?" and "how far will each movement go?" The analogy also explains why maximal speed is not automatically optimal. Taking an elevator as fast and as far as possible may be exactly what one patient wants and tolerates; another may prefer smaller jumps with more time between them. Medical optimization asks which trajectory best serves the individual, not which setting maximizes the numbers. 459. Logician model: typed state-transition system For a logician, the system is a typed, partially independent transition system. Each endocrine channel i has input pair (C_i,R_i), a jump-size function J_i, a timing function T_i, and a typed coordinate-update relation. Global state identity includes the five-coordinate address plus InternalHGLDescriptor and history. The transition relation is constrained by boundedness on four axes, unboundedness on Hyperstage, receptor/hormone gating, closure prerequisites, and no automatic carry/regression. Psychological/social/relational predicates lie outside the pure stage-transition logic unless a causal bridge maps endocrine/history variables to them. 460. AI implementation rules AI-ENDO-1: Store Address(H,S,U,U2,U3) as five separately typed coordinates. AI-ENDO-2: Store InternalHGLDescriptor separately; do not count it as another hormone-controlled coordinate. AI-ENDO-3: Preserve the base selector U2=1/2/3/4 -> Supra/Hyper/Ultra/Apex. AI-ENDO-4: Preserve superscript HF^n versus subscript HF_n nonidentity where both notations are used. AI-ENDO-5: Store hormone amount and receptor sensitivity separately for each axis. AI-ENDO-6: Never infer jump magnitude from amount alone or interval from sensitivity alone under the orthogonal model. AI-ENDO-7: Enforce H unbounded; enforce S,U,U2,U3 <= Omega_H. AI-ENDO-8: Never auto-carry overflow into a parent coordinate or auto-reset lower coordinates after a parent jump. AI-ENDO-9: Requested endocrine jump does not waive HGL construction prerequisites. AI-ENDO-10: Distinguish logical D, structural HI, causal CD, plausible CI, illustrative ILL, and OPEN medical/research claims. 461. Clinical conformance examples Example 1 — same Raeyol amount, greater receptor sensitivity: same canonical timing input, larger Hyperstage jump. D/CD under the adopted endocrine law. Example 2 — greater Raeyol amount, same sensitivity: shorter interval, same canonical jump magnitude. D/CD. Example 3 — complete Raeyol receptor insensitivity with very high Raeyol amount: no Raeyol-driven Hyperstage increase. D/CD. Example 4 — high Alygorin amount plus low Alygorin sensitivity: rapid but small Stage jumps. D/CD. Example 5 — low Zilanin amount plus high Zilanin sensitivity: infrequent but large Substage^2 jumps, never beyond Omega_H in one Hyperstage. D/CD. Example 6 — same final Archaddress after different regimens: identical final address is possible, identical wellbeing/phenotype history is not deduced. D for nonentailment; CI for possible differences. Example 7 — very rapid regimen causes discomfort in Patient A: CD only if A-specific causal/clinical law is established; otherwise CI. Example 8 — high Apexfemale address means psychological distress: reject. No such theorem exists. Example 9 — lower hormone dose means stage regression: reject. It changes future drive, not attained address.
Source Canon: Verbatim mathematical and modal logic. Interactive navigation and operator lookups available at /#hgl-part:289.